Brooks K, Tawk K, Djalilian H, Hobson C
Laryngoscope Investig Otolaryngol. 2023; 8(4):1080-1093.
PMID: 37621262
PMC: 10446291.
DOI: 10.1002/lio2.1109.
Sasmita B, Xie S, Liu G, Zhu Y, Luo S, Huang B
Egypt Heart J. 2023; 75(1):25.
PMID: 37024594
PMC: 10079792.
DOI: 10.1186/s43044-023-00351-8.
Wade C, Wells J
Expert Rev Respir Med. 2020; 14(7):671-678.
PMID: 32250198
PMC: 7365250.
DOI: 10.1080/17476348.2020.1752671.
Formgren H
Br J Clin Pharmacol. 2012; 3(6):1007-14.
PMID: 22216522
PMC: 1428965.
DOI: 10.1111/j.1365-2125.1976.tb00350.x.
Prichard B
Proc R Soc Med. 2010; 70(Suppl 5):40-4.
PMID: 20919347
PMC: 1542839.
Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.
Yang H, Wu W, Bodor N
Pharm Res. 1995; 12(3):329-36.
PMID: 7617516
DOI: 10.1023/a:1016283930696.
Adverse effects of antihypertensive drugs.
Husserl F, Messerli F
Drugs. 1981; 22(3):188-210.
PMID: 7021123
DOI: 10.2165/00003495-198122030-00002.
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?.
McDevitt D
Drugs. 1983; 25(4):331-8.
PMID: 6133735
DOI: 10.2165/00003495-198325040-00001.
Bronchial asthma in adults: presentation to the emergency department. Part I: Pathogenesis, clinical manifestations, diagnostic evaluation, and differential diagnosis.
Brenner B
Am J Emerg Med. 1983; 1(1):50-70.
PMID: 6097275
PMC: 7134914.
DOI: 10.1016/0735-6757(83)90038-4.
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Harrison D
Drugs. 1974; 7(1):1-7.
PMID: 4152164
DOI: 10.2165/00003495-197407010-00001.
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi G, Fiocchi G
Cardiovasc Drugs Ther. 1990; 4(4):1145-9.
PMID: 1982059
DOI: 10.1007/BF01856511.
Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients.
Christensen C, Boye N, ERIKSON H, Hansen G
Eur J Clin Pharmacol. 1978; 13(1):9-12.
PMID: 346356
DOI: 10.1007/BF00606674.
Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.
McDevitt D
Drugs. 1979; 17(4):267-88.
PMID: 37065
DOI: 10.2165/00003495-197917040-00002.
The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
Prichard B
Br J Clin Pharmacol. 1978; 5(5):379-99.
PMID: 26370
PMC: 1429347.
DOI: 10.1111/j.1365-2125.1978.tb01644.x.
Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.
Cocco G, Burkart F, Chu D, Follath F
Eur J Clin Pharmacol. 1978; 13(1):1-4.
PMID: 25186
DOI: 10.1007/BF00606672.
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Wollam G, GIFFORD Jr R, TARAZI R
Drugs. 1977; 14(6):420-60.
PMID: 23284
DOI: 10.2165/00003495-197714060-00002.
Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease.
Johnsson G
Drugs. 1976; 11 SUPPL 1:171-7.
PMID: 6250
DOI: 10.2165/00003495-197600111-00035.